Return to MD Anderson Cancer Center

Return to Department of Thoracic and Cardiovascular Surgery

What's New
Faculty & Staff
  Jack Roth, M.D.
    Curriculum Vitae
    Invited Articles
Education
Specific Diseases
Videos
Research
F.A.Q.
Glossary of Terms
Web Links
Thoracic Center
Contact Information

 

  

Bibliography - Jack A. Roth, M.D.

Published and accepted invited journal articles

  1. Roth, J.A. Collective review: tumor induced immunosuppression. Surg. Gynecol. Obstet., 156:223-240, 1983.
  2. Tomasovic, S.P. and Roth, J.A. Therapy for metastasis. Bull. Cancer, 39:219-224, 1987.
  3. Roth, J.A. Biochemical and cytogenetic studies of human lung cancer. J. Thorac. Cardiovasc. Surg., 96:847-848, 1988. Discussion.
  4. Pollock, R.E. and Roth, J.A. Cancer-induced immunosuppression: Implications for therapy Semin. Surg. Oncol., 5:414-419, 1989.
  5. Roth, J.A. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann. Thorac. Surg., 47:669-677, 1989. Discussion.
  6. Roth, J.A. Esophageal cancer: is esophagectomy necessary. Oncology, 3:110-111, 1989. Commentary
  7. Ryan, M.B., McMurtrey, M.J., and Roth, J.A. Current management of chest-wall tumors. Surg. Clin. North Am., 69:1061-1080, 1989.
  8. Putnam, J.B., Jr., and Roth, J.A. Prognostic indicators in patients with pulmonary metastases. Semin. Surg. Oncol., 6:291-296, 1990.
  9. Roth, J.A., Ajani, J., and Rich, T.A. Multidisciplinary therapy for esophageal cancer. Adv. Surg., 23:239-260, 1990.
  10. Roth, J.A. Resection of pulmonary metastases from osteogenic sarcoma. Bull. Cancer, 42:344-346, 1990.
  11. Casson, A.G., Mukhopadhyay, T., Cleary, K.R., Ro, J.Y., Levin, B., and Roth, J.A. Oncogene activation in esophageal cancer. J. Thorac. Cardiovasc. Surg., 102:707-709, 1991.
  12. Ellerbroek, N.A., Fossella, F.V., Rich, T.A., Ajani, J.A., Komaki, R., Roth, J.A., and Holoye, P.Y. Low-dose continuous infusion cisplatinum combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. (Comment). Int. J. Radiat. Oncol. Biol. Phys., 21: 869-870, 1991.
  13. Gorenstein, L.A., Putnam, J.B. Jr., Natarajan, G., Balch, C.A., and Roth, J.A. Improved survival after resection of pulmonary metastases from malignant melanoma. Ann. Thorac. Surg., 52:178-179, 1991. Commentary.
  14. Pogrebniak, H.W., Roth, J.A., Steinberg, S.M., Rosenberg, S.A., and Pass, H.I. Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann. Thorac. Surg., 52:178-179, 1991. Commentary.
  15. Roth, J.A. What's new in surgery: surgical oncology. American College of Surgeons, 76:30-33, 1991.
  16. Roth, J.A., and Balch, C.M. Thoracic surgery training: it is time for a change. Ann. Thorac. Surg., 51:818-819, 1991. Editorial.
  17. Roth, J.A. The molecular pathology of colorectal carcinoma. Curr. Surg., 48:491-492, 1991.
  18. Roth, J.A. Operative treatment for small cell lung cancer. Langenbecks Arch. Chir., 376:375-378, 1991. Panel Discussion.
  19. Roth, J.A. Antisense RNA technology successfully blocks K-ras induced cancer. M. D. Anderson Oncology, 36:1, 2, & 7, 1991.
  20. Roth, J.A. Lung Cancer: rational strategies for early detection and intervention. Oncology, 5:25-33, 1991. Article Reviewed.
  21. Roth, J.A. A second opinion on the early detection of lung cancer. Primary Care and Cancer, 11:20-21, 1991. Interview.
  22. Slater, J.D., Ellerbroek, N.A., Barkley, H., Mountain, C.F., Oswald, M.J., Roth, J.A., and Peters, L.J. Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 20:1137-1141, 1991. Commentary.
  23. Cybulsky, I.J., Lanza, L.A., Ryan, M.B., Putnam, J.B., Jr., McMurtrey, M.M., and Roth, J.A. Prognostic significance of computed tomography in resected N2 lung cancer. Ann. Thorac. Surg., 55:1593-1593, 1992.
  24. Morice, R.C., Peters, E.J., Ryan, M.B., Putnam, J.B., Jr., Ali, M.K., and Roth, J.A. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest, 101:300-301, 1992. Commentary.
  25. Roth, J.A. Molecular surgery for cancer. Arch. Surg., 127:1298-1302, 1992. Review.
  26. Roth, J.A. Pulmonary resection for metastatic breast cancer. Breast Diseases: A Year Book Quarterly, 1992. Commentary.
  27. Roth, J.A. Recent studies in molecular biology of lung cancer. CME Program, University of California, 11-15, 1992.
  28. Roth, J.A. Neoadjuvant therapy for esophageal cancer. Curr. Surg., 49:462-467, 1992. Guest Reviewer.
  29. Roth, J.A. Squamous cell cancer of the esophagus. Treatment concept at the Houston M. D. Anderson Cancer Center Houston. Der Chirurg, 63:683-688, 1992.
  30. Roth, J.A., Mukhopadhyay, T., Tainsky, M.A., Fang, K., Casson, A.G., and Schneider, P.M. Molecular approaches to prevention and therapy of aerodigestive tract cancers. J. Natl. Cancer Inst., 13:15-21, 1992. Review.
  31. Roth, J.A. Esophageal cancer: does preoperative chemotherapy make a difference J. Surg. Oncol., 50:67-69, 1992. Editorial.
  32. Roth, J.A. The Grillo article. Oncology, 6:72-72, 1992. Article Reviewed.
  33. Roth, J.A. Genetic etiology of lung cancer. Oncology, 6:111-112, 1992. Otterson Article Reviewed.
  34. Schneider, P.M., Casson, A.G., and Roth, J.A. Detection of malignant potential in Barrett's epithelium. Dis. Esophagus, 5:45-50, 1992.
  35. Ajani, J.A., Roth, J.A., Ryan, M.B., Putnam, J.B., Pazdur, R., Levin, B., Gutterman, JU, and McMurtrey, M. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J. Clin. Oncol., 11:1-2, 1993. Commentary.
  36. Lanza, L.A., Natarajan, G., Roth, J.A., and Putnam, J.B. Long-term survival following resection of pulmonary metastases from carcinoma of the breast. Res. Dis. Digest, 2:16-16, 1993.
  37. Putnam, J.B. and Roth, J.A. Resection of sarcomatous pulmonary metastases. Surg. Oncol. Clin. N. Am., 673-691, 1993.
  38. Roth, J.A. Modulation of oncogene and tumor suppressor gene expression: a novel strategy for cancer therapy and prevention. Ann. Surg. Oncol., 1:79-86, 1993.
  39. Roth, J.A. Targeting cancer genes: a novel approach to cancer prevention and therapy. Bull. Cancer, 45:171-177, 1993.
  40. Roth, J.A. Oncogenes: what role in cancer therapy? Contemp. Oncol., 3:40-52, 1993.
  41. Roth, J.A. Recombinant DNA Advisory Committee. Minutes of Meeting of September 14-15, 1992. Hum. Gene Ther., 4:365-389, 1993.
  42. Roth, J.A., Mukhopadhyay, T., Casson, A.G., and Chung, K.Y. Molecular strategies for early detection, prevention, and therapy of cancer. NCI Workshop EDCOP, 1993.
  43. Roth, J.A. Adenocarcinoma arising in the columnar lined esophagus: is it multifocal or diffuse? Polydisciplinary International Congress, 1993.
  44. Roth, J.A. Targeting lung cancer genes: a novel approach to cancer prevention and therapy. Semin. Thorac. Cardiovasc. Surg., 5:178-183, 1993.
  45. Roubein, L.D., DuBrow, R., David, C., Lynch, P., Fornage, B., Ajani, J., Roth, J.A., and Levin, B. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction. Endoscopy, 25:587-591, 1993.
  46. Fujiwara, T., Grimm, E.A., and Roth, J.A. Gene therapeutics and gene therapy for cancer. Curr. Opin. Oncol., 6:96-105, 1994.
  47. Fujiwara, T., Cai, D.W., Georges, R.N., Mukhopadhyay, T., Grimm, E.A., and Roth, J.A. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J. Natl. Cancer Inst., 86:1437-1438, 1994. Commentary.
  48. Fujiwara, T., Cai, D.W., Georges, R.N., Mukhopadhyay, T., Grimm, E.A., and Roth, J.A. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J. Natl. Cancer Inst., 86:1458-1462, 1994.
  49. Maxwell, S.A. and Roth, J.A. Posttranslational regulation of p53 tumor suppressor protein function. Crit. Rev. Oncog., 5:23-57, 1994.
  50. Roth, J. A. Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment. Ann. Surg. Oncol., 1:79-86, 1994. Review.
  51. Roth, J.A. What is a surgical oncologist? Ann. Surg. Oncol., 1:2-4, 1994. Commentary.
  52. Roth, J.A. The cell and molecular biology of esophageal carcinoma. Chest Surg. Clin. N. Am., 4:205-216, 1994.
  53. Roth, J.A., Holscher, A.H., and Schneider, P.M. Markers of malignant potential and clinical management of dysplasia in Barrett esophagus. Chirurg, 65:96-101, 1994. Review.
  54. Roth, J.A. Gene replacement strategies for the prevention and therapy of lung cancer. Eur. J. Cancer, 11:66-67, 1994.
  55. Roth, J.A., Mukhopadhyay, T., Zhang, W.W., Fujiwara, T., and Georges, R. Gene replacement strategies for the prevention and therapy of cancer. Eur. J. Cancer, 30A:2032-2037, 1994.
  56. Roth, J.A., Fossella, F., Komaki, R., Ryan, M.B., Putnam, J.B., Jr., Lee, J.S., Dhingra, H., DeCaro, L., Chasen, M., and McGavran, M. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J. Natl. Cancer Inst., 86:650-651, 1994. Commentary.
  57. Roth, J.A. Surgical approaches to locally advanced potentially resectable non-small cell lung cancer. Lung Cancer, 11:S25-S30, 1994.
  58. Roth, J.A., and Putnam, J.B., Jr. Surgery for cancer of the esophagus. Semin. Oncol., 21:453-461, 1994.
  59. Zhang, W.W., and Roth, J.A. Anti-oncogene and tumor suppressor gene therapyexamples from a lung cancer animal model. In Vivo, 8:755-769, 1994.
  60. Zhang, Y., Mukhopadhyay, T., and Roth, J.A. Antisense strategy for molecular targeting of mutated K-ras oncogene in lung cancer. Acta Oncologica Sinica, 4:17-21, 1994.
  61. Cristiano, R.J. and Roth, J.A. Molecular conjugates: a targeted gene delivery vector for molecular medicine. J. Mol. Med., 73 479-486, 1995.
  62. Komaki, R., Shin, D.M., Glisson, B.S., Fossella, F.V., Murphy, W.K., Garden, A.S., Oswald, M.J., Hong, W.K., Roth, J.A., and Peters, L.J. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 31:1019-1020, 1995. Commentary.
  63. Mukhopadhyay, T. and Roth, J.A. Antisense technology. Bull. Cancer, 47:420-422, 1995.
  64. Mukhopadhyay, T. and Roth, J.A. Antisense therapy for cancer. Cancer J. Sci. Am., 1:233-242, 1995.
  65. Roth, J.A. The training and preservation of thoracic surgeon scientists. Chest Surg. Clin. N. Am., 5:7-16, 1995.
  66. Roth, J.A. Review: Clinical protocol for modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin. Hum. Gene Ther., 6:252-255, 1995.
  67. Roth, J.A. Molecular events in lung cancer. Lung Cancer, 12:S3-S15, 1995.
  68. Roth, J.A. Analysis of tumor suppressor genes. Methods, 8: 167-169, 1995. Editorial.
  69. Roth, J.A. Multimodality treatment of cancer arising from Barrett's epithelium. World J. Surg., 19:205-209, 1995.
  70. Schneider, P.M., Casson, A.G., and Roth, J.A. Malignant degeneration of Barrett's esophagus: the role of the p53 tumour-suppressor-gene. Dis. Esophagus, 8:99-103, 1995.
  71. Swisher, S.G., Roth, J.A., and Putnam, J.B., Jr. Diagnosis and management of benign esophageal tumors. Cancer Bull, 47:396-401, 1995.
  72. Walsh, G.L., O'Connor, M., Willis, K.M., Milas, M., Wong, R.S., Nesbitt, J.C., Putnam, J.B., Jr., Lee, J.J., and Roth, J.A. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann. Thorac. Surg., 60:1563-1572, 1995.
  73. Zhang, W.W., Fujiwara, T., Grimm, E.A., and Roth, J.A. Advances in cancer gene therapy. Adv. Pharmacol., 32:289-341, 1995.
  74. Fossella, F.V., Rivera, E., and Roth, J.A. Preoperative chemotherapy for stage IIIa non-small cell lung cancer. Curr. Opin. Oncol., 8:106-111, 1996. Review.
  75. Fujiwara, T., Kagawa, S., Ogawa, N., Yasuda, T., Tanaka, N., Orita, K., Cai, D.W., Zhang, W.W., and Roth, J.A. Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer. Hum. Cell, 9:25-30, 1996. Review.
  76. Fujiwara, T., Ogawa, N., Kagawa, S., Nishizaki, M., Yasuda, T., Tanaka, N., Orita, K., and Roth, J.A. Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin [Japanese]. J. Cancer Chemother., 23:1085-1088, 1996.
  77. Mukhopadhyay, T., and Roth, J.A. Antisense regulation of oncogenes in human cancer. Crit. Rev. Oncog., 7:151-190, 1996.
  78. Roth, J.A., Beech, D.J., Putnam, J.B. Jr., Pollock, R.E., Patel, S.R., Fidler, I.J., and Benjamin, R.S. Treatment of the patient with lung metastases. Curr. Prob. Surg., 33:881-952, 1996. Review.
  79. Roth, J.A. Gene replacement strategies for cancer. Isr. J. Med. Sci., 32:89-94, 1996.
  80. Roth, J.A. Retrovirus-mediated p53 gene therapy. Nat. Med., 2:1163-1163, 1996. Reply.
  81. Roth, J.A. Surgical management of lung metastases: selection factors and results. Oncology, 10:655-656, 1996. Article Reviewed.
  82. Roth, J.A., Mukhopadhyay, T., Zhang, W.W., Fujiwara, T., and Georges, R. Gene replacement strategies for lung cancer. Sem. Radiat. Oncol., 6:105-109, 1996.
  83. Bunn, P., Carbone, D., Grim, J., Harris, C., Havemann, K., Mabry, M., Roth, J., Saijo, N., Poulsen, H.S., Stahel, R., Takahashi, T., and Twentyman, P. Meeting report - Fifth IASLC lung tumor biology workshop, August 13-17, 1996, Ermatingen, Switzerland. Ann. Oncol., 8:27-36, 1997.
  84. Bunn, P., Carbone, D., Grim, J., Harris, C., Havemann, K., Mabry, M., Roth, J., Saijo, N., Poulsen, H.S., Stahel, R., Takahashi, T., and Twentyman, P. Meeting report - Fifth IASLC lung tumor biology workshop, August 13- 17, 1996, Ermatingen, Switzerland. Lung Cancer, 16:239-257, 1997.
  85. Kataoka, M., Komaki, R., and Roth, J.A. Gene therapy for lung cancer patients wild-type p53 gene transfer mediated by retrovirus. Exp. Med., 15:251-253, 1997.
  86. Roth, J.A., and Cristiano, R.J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89:21-39, 1997. Review
  87. Roth, J.A., Nguyen, D., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Ferson, D.Z., Hong, W.K., Komaki, R., Lee, J.J., Nesbitt, J.C., Pisters, K.M.W., Putnam, J.B., Schea, R., Shin, D.M., Walsh, G.L., Dolormente, M.M., Han, C.I., Martin, F.D., Yen, N., Xu, K., Stephens, L.C., McDonnell, T.J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Med. Briefs Cancer, 2:4-5, 1997.
  88. Schneider, P.M., Casson, A.G., Holscher, A.H., Schweighart, S., Mizumoto, S., Siewert, J.R., and Roth, J.A. Molecular pathogenesis of adenocarcinomas in Barrett's esophagus - role of the tumor suppressor gene p53. Onkologie, 20:36-40, 1997.
  89. Ginsberg, R., Roth, J.A., and Fergusson, M. Esophageal cancer surgical practice guidelines. Esophageal cancer practice guideline committee. Oncology (Huntington), 11:1059-1062, 1065, 1997.
  90. Ginsberg, R., Roth, J.A., and Fergusson, M. Lung cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. Oncology (Huntington), 11:889-892, 895, 1997.
  91. Roth, J.A., Swisher, S.G., Bouvet, M., and Merritt, J.A. p53 gene replacement therapy in lung cancer. Adv. Oncol., 14:2-7, 1998.
  92. Roth, J.A. Gene replacement strategies for lung cancer. Curr. Opin. Oncol., 10:127-132, 1998.
  93. Swisher, S.G. and Roth, J.A. Gene therapy for human lung cancers. Surg. Oncol. Clin. N. Am., 7:603-616, 1998.
  94. Cristiano, R.J., Xu, B., Nguyen, D., Schmacher, G., Kataoka, M., Sptiz, F.R., and Roth, J.A. Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect. Prev., 22:445-454, 1998.
  95. Nguyen, D.M., Cristiano, R.J., Sptiz, F.R., and Roth, J.A. p53 gene replacement therapy for lung cancer. J. Cardiovac. Surg., 39:145-154, 1998.
  96. Pearson, A.S., Bouvet, M., Evans, D.B., and Roth, J.A. Gene therapy and pancreatic cancer. Front. Biosci., 3:E230-E237, 1998.
  97. Roth, J.A. Significance of p53 and Rb protein expression in surgically treated non-small cell lung cancers. Ann. Thorac. Surg., 68:348, 1999.
  98. Roth, J.A. p53 prognostication: paradigm or paradox? Clin. Cancer Res., 5:3345, 1999. Editorial.
  99. Roth, J.A., Swisher, S.G., and Meyn, R.E. p53 tumor suppressor gene therapy for cancer. Oncology (Huntington), 13:148-154,1999.
  100. Roth, J.A. Reply to Grannis. Lung Cancer, 28:251, 2000.
  101. Toloza, E.M., Roth, J.A., and Swisher, S.G. Molecular events in bronchogenic carcinoma and their implications for therapy. Semin. Surg. Oncol., 18:91-99, 2000.
  102. Pataer, A., Fang, B., Roth, J.A., and Swisher, S.G. Adenoviral bak overexpression mediates caspase-dependent tumor killing. Cancer Res. Alert, 2:17-19, 2000.
  103. Roth, J.A. Restoring a tumor-suppressor gene. The Genesis Report, 2000.
  104. Roth, J.A., Swisher, S.G., and Meyn, R.E. p53 tumor suppressor gene therapy for cancer. Oncology, 13:148-154,1999.
  105. Roth,J.A., Grammer, S.F., Swisher, S.G., Nemunaitis, J., Merritt, J., and, Meyn, R.E., Jr. Gene replacement strategies for treating non-small cell lung cancer. Semin. Radiat. Oncol., 10:333-342, 2000.

Back to Top